Quantitative analysis of Epstein-Barr virus load by using a real-time PCR assay

Journal of Clinical Microbiology

Volumn 37, Issue 1, 1999, Pages 132-136

  Kimura, Hiroshi ^a   Morita, Makoto ^a   Yabuta, Yumi ^a   Kuzushima, Kiyotaka ^b   Kato, Koji ^c   Kojima, Seiji ^c   Matsuyama, Takaharu ^c   Morishima, Tsuneo ^a  

^a NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b AICHI CANCER CENTER HOSPITAL   (Japan)

^c JAPANESE RED CROSS NAGOYA FIRST HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA;

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; EPSTEIN BARR VIRUS; HUMAN; HUMAN CELL; IN SITU HYBRIDIZATION; INFECTIOUS MONONUCLEOSIS; LYMPHOPROLIFERATIVE DISEASE; MALE; MONONUCLEAR CELL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUANTITATIVE ASSAY; VIRUS INFECTION; VIRUS LOAD;

DNA VIRUSES; HUMAN HERPESVIRUS 4;

EID: 0032930344     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/jcm.37.1.132-136.1999     Document Type: Article

References (37)

1. Baer, R., A. T. Bankier, M. D. Biggin, et al. 1984. DNA sequence and expression of the B95-8 Epstein-Barr virus genome. Nature 310:207-211.
2. Bai, X., G. Hosler, B. B. Rogers, D. B. Dawson, and R. H. Scheuermann. 1997. Quantitative polymerase chain reaction for human herpesvirus diagnosis and measurement of Epstein-Barr virus burden in posttransplant lymphoproliferative disorder. Clin. Chem. 43:1843-1849.
3. Beutler, E., T. Gelbart, and W. Kuhl. 1990. Interference of heparin with the polymerase chain reaction. BioTechniqucs 9:2-3.
4. Gan, Y. J., J. L. Sullivan, and J. W. Sixbey. 1994. Detection of cell-free Epstein-Barr virus DNA in serum during acute infectious mononucleosis. J. Infect. Dis. 170:436-139.
5. Gratama, J. W. 1994. Epstein-Barr virus infections in bone marrow transplantation recipients, p. 429-442. In S. J. Forman, K. G. Blume, and E. D. Thomas (ed.). Bone marrow transplantation. Blackwell Scientific Publications, Boston. Mass.
6. Hanto, D. W., G. Frizzera, K. J. Gajl-Peczalska, K. Sakamoto, D. T. Purtilo, H. Balfour, Jr., R. L. Simmons, and J. S. Najarian. 1982. Epstein-Barr virus-induced B-cell lymphoma after renal transplantation: acyclovir therapy and transition from polyclonal to monoclonal B-cell proliferation. N. Engl. J. Med. 306:913-918.
7. Heid, C. A., J. Stevens, K. J. Livak, and P. M. Williams. 1996. Real time quantitative PCR. Genome Res. 6:986-994.
8. Heslop, H. E., C. Y. Ng, C. Li, C. A. Smith, S. K. Loftin, R. A. Krance, M. K. Brenner, and C. M. Rooney. 1996. Long-term restoration of immunity against Epstein-Barr virus infection by adoptive transfer of gene-modified virus-specific T lymphocytes. Nat. Med. 2:551-555.
9. Hironaka, T., M. Nagasaki, S. Morikawa, and K. Hirai. 1993. Detection of Epstein-Barr virus transcripts in chemically or immunologically-activated cells and in a null cell-line (HLN-STL-C) by in situ hybridization with alkaline phosphatase-linked oligonucleotide probes. J. Virol. Methods 44: 141-154.
10. Imai, S., M. Sugiura, O. Oikawa, et al. 1996. Epstein-Barr virus (EBV)-carrying and -expressing T-cell lines established from severe chronic active EBV infection. Blood 87:1446-1457.
11. Imashuku, S., T. Goto, T. Matsumura, M. Naya, M. Yamori, M. Hojo, S. Hibi, and S. Todo. 1997. Unsuccessful CTL transfusion in a case of post-BMT Epstein-Barr virus-associated lymphoproliferative disorder (EBV-LPD). Bone Marrow Transpl 20:337-340.
12. Jones, M. D., and B. E. Griffin. 1983. Clustered repeat sequences in the genome of Epstein-Barr virus. Nucleic Acids Res. 11:3919-3937.
13. Kiraura, H., I. Tsuge, S. Imai, M. Yamamoto, K. Kuzushima, T. Osato, and T. Morishima. 1995. Intact antigen presentation for Epstein-Barr virus (EBV)-specific CTL by a lymphoblastoid cell line established from a patient with severe chronic active EBV infection. Med. Microbiol. Immunol. 184: 63-68.
14. Kimura, H., Y. Wang, L. Pesnicak, J. I. Cohen, J. J. Hooks, S. E. Straus, and R. K. Williams. 1998 Recombinant varicella-zoster virus glycoproteins E and I: immunologic responses and clearance of virus in a guinea pig model of chronic uveitis. J. Infect. Dis. 178:310-317.
15. Kuzushima, K., M. Yamamoto, H. Kimura, Y. Ando, T. Kudo, I. Tsuge, and T. Morishima. 1996. Establishment of anti-Epstein-Barr virus (EBV) cellular immunity by adoptive transfer of virus-specific cytotoxic T lymphocytes from an HLA-matched sibling to a patient with severe chronic active EBV infection. Clin. Exp. Immunol. 103:192-198.
16. Lin, H. J., T. Tanwandee, and F. B. Hollinger. 1997. Improved methods for quantification of human immunodeficiency virus type I RNA and hepatitis C virus RNA in blood using spin column technology and chemiluminescent assays of PCR products. J. Med. Virol. 51:56-63.
17. Morita, M., I. Tsuge, H. Matsuoka, Y. Ito, T. Itosu, M. Yamamoto, and T. Morishima. 1998. Calcification in the basal ganglia with chronic active Epstein-Ban virus infection. Neurology 40:1485-1488.
18. Nakazawa, Y., H. Chisuwa, T. Ikegami, Y. Hashikura, H. Matsunami, T. Ichikawa, T. Oh-ishi, and S. Kawasaki. 1997. Efficacy of quantitative analysis of Epstein-Barr virus-infected peripheral blood lymphocytes by in situ hybridization of EBER1 after living-related liver transplantation: a case report. Transplantation 43:1363-1366.
19. Okano, M., S. Matsumoto, T. Osato, Y. Sakiyama, G. M. Thiele, and D. T. Purtilo. 1991. Severe chronic active Epstein-Barr virus infection syndrome. Clin. Microbiol. Rev. 4:129-135.
20. Papadopoulos, E. B., M. Ladanyi, D. Emanuel, et al. 1994. Infusions of donor leukocytes to treat Epstein-Barr virus-associated lymphoproliferative disorders after allogeneic bone marrow transplantation. N. Engl. J. Med. 330:1185-1191.
21. Pardoe, I. U., and T. I. Michalak. 1995. Detection of hepatitis B and woodchuck hepatitis viral DNA in plasma and mononuclear cells from heparinized blood by the polymerase chain reaction. J. Virol. Methods 51:277-288.
22. Purtilo, D. T., R. S. Strobach, M. Okano, and J. R. Davis. 1992. Epstein-Barr virus-associated lymphoproliferative disorders. Lab. Investig. 67:5-23.
23. Randhawa, P. S., R. Jaffe, A. J. Demetris, M. Nalesnik, T. E. Starzl, Y. Y. Chen, and L. M. Weiss. 1992. Expression of Epstein-Barr virus-encoded small RNA (by the EBER-1 gene) in liver specimens from transplant recipients with post-transplantation lymphoproliferative disease. N. Engl. J. Med. 327:1710-1714.
24. Rickinson, A. B. 1986. Chronic, symptomatic Epstein-Barr virus infection, Immunol. Today 7:13-14.
25. Rickinson, A. B., and E. Kieff. 1996. Epstein-Barr virus, p. 2397-2446. In B. N. Fields, D. M. Knipe, and P. M. Howly (ed.), Virology. Lippincott-Raven Publishers, Philadelphia, Pa.
26. Riddler, S. A., M. C. Breinig, and J. L. McKnight. 1994. Increased levels of circulating Epstein-Barr virus (EBV)-infected lymphocytes and decreased EBV nuclear antigen antibody responses are associated with the development of posttransplant lymphoproliferative disease in solid-organ transplant recipients. Blood 84:972-984.
27. Rooney, C. M., S. K. Loftin, M. S. Holladay, M. K. Brenner, R. A. Krance, and H. E. Heslop. 1995. Early identification of Epstein-Barr virus-associated post-transplantation lymphoproliferative disease. Br. J. Haematol. 89:98-103.
28. Rooney, C. M., C. A. Smith, C. Y. Ng, S. Loftin, C. Li, R. A. Krance, M. K. Brenner, and H. E. Heslop. 1995. Use of gene-modified virus-specific T lymphocytes to control Epstein-Barr-virus-related lymphoproliferation. Lancet 345:9-13.
29. Rowe, D. T., L. Qu, J. Reyes, N. Jabbour, E. Yunis, P. Putnam, S. Todo, and S. Green. 1997. Use of quantitative competitive PCR to measure Epstein-Barr virus genome load in the peripheral blood of pediatric transplant patients with lymphoproliferative disorders. J. Clin. Microbiol. 35:1612-1615.
30. Savoie, A., C. Perpete, L. Carpentier, J. Joncas, and C. Alfieri. 1994. Direct correlation between the load of Epstein-Barr virus-infected lymphocytes in the peripheral blood of pediatric transplant patients and risk of lymphoproliferative disease. Blood 83:2715-2722.
31. Straus, S. E. 1988. The chronic mononucleosis syndrome. J. Infect. Dis. 157:405-412.
32. Straus, S. E., J. I. Cohen, G. Tosato, and J. Meier. 1993. NIH conference. Epstein-Barr virus infections: biology, pathogenesis, and management. Ann. Intern. Med. 118:45-58.
33. Swerdlow, S. H. 1992. Post-transplant lymphoproliferative disorders: a morphologic, phenotypic and genotypic spectrum of disease. Histopathology 20:373-385.
34. Wang, A. M., and D. F. Mark. 1990. Quantitative PCR, p. 70-75. In M. A. Innis, D. H. Gelfand, J. J. Sninsky, and T. J. White (ed.), PCR protocols. Academic Press. Inc., San Diego, Calif.
35. Williams, P. M., S. J. Williams, C. Schwer, A. S. Krishnarao, C. Heid, B. L. Karger, and P. M. Williams. 1996. Real time quantitative PCR. Quantitative competitive polymerase chain reaction: analysis of amplified products of the HIV-I gag gene by capillary electrophoresis with laser-induced fluorescence detection. Genome Res. 6:146-152.
36. Williams, S. J., C. Schwer, A. S. Krishnarao, C. Heid, B. L, Karger, and P. M. Williams. 1996 Quantitative competitive polymerase chain reaction: analysis of amplified products of the HIV-I gag gene by capillary electrophoresis with laser-induced fluorescence detection. Anal. Biochem. 236:146-152.
37. Yamamoto, M., H. Kimura, T. Hironaka, K. Hirai, S. Hasegawa, K. Kuzushima, M. Shibata, and T. Morishima. 1995. Detection and quantification of virus DNA in plasma of patients with Epstein-Barr virus-associated diseases. J. Clin. Microbiol. 33:1765-1768.